Lifestyles Factors May Contribute to Increased Early-Onset Cancer Incidence

Commentary
Video

Rates of obesity appear to correlate with increasing incidence of cancer in young populations, according to Monique Gary, DO, MSc, FACS.

In a conversation with CancerNetwork®, Monique Gary, DO, MSc, FACS, discussed how certain lifestyle factors including smoking, obesity status, and physical activity may be associated with a rise in early-onset cancer, including in breast and gastrointestinal (GI) disease.

According to Gary, a breast surgeon and medical director at Grand View Health, findings from a study published in JAMA Network Open highlighted an increase in incidence of early-onset cancer from 2010 to 2019, including those with GI cancers. Although she indicated that there were no definitive conclusions that could be drawn from the study, Gary said that rates of obesity appeared to parallel the rising incidence of early-onset disease during this period. Based on this correlation, she suggested that increases in weight may account for the increasing rate of cancer incidence.

Transcript:

There are no definitive explanations that came out of this study. This was a study that was population-wide and designed to look at a cross-section of where we are and see where there might be some leads. There were some interesting associations with things like smoking, obesity, and physical activity. When you look at the number of gastrointestinal cancers, for example, that have increased, those are all going to be related to those risk factors [seen in] sedentary lifestyles. There are some opportunities for us to do some interventions on that population’s health and wellness because much of what we’re seeing has a lot to do with what’s been happening to us as a society.

What I mean by that is, when you look at even the rates of obesity, they’re mirroring the rates of increase in cancer in young people. We know that younger people are struggling with their weight. Those increases are probably going to—at least we believe in the scientific community—result in some increased cancer incidence and may be part of the phenomenon that we’re experiencing.

Reference

Koh B, Hao Tan DJ, Ng HN, et al. Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019. JAMA Netw Open. 2023;6(8):e2328171. doi:10.1001/jamanetworkopen.2023.28171

Recent Videos
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Establishment of an AYA Lymphoma Consortium has facilitated a process to better understand and address gaps in knowledge for this patient group.
Adult and pediatric oncology collaboration in assessing nivolumab in advanced Hodgkin lymphoma facilitated the phase 3 SWOG S1826 findings.
Treatment paradigms differ between adult and pediatric oncologists when treating young adults with lymphoma.
Differences in pancreatic cancer responses to treatment elicits a need to better educate patients on expectations in treatment, particularly chemotherapy.
Increasing patient awareness of modifiable risk factors for pancreatic cancer may help mitigate incidence of pancreatic cancers.
It may be crucial to test every patient for markers such as BRAF V600E mutations, NRG1 fusions, and KRAS G12C mutations to help manage pancreatic cancers.
Tanios S. Bekaii-Saab, MD, emphasizes the idea of moving targeted therapies to earlier lines of treatment to further improve outcomes in pancreatic cancer.
Related Content